Published in Br J Cancer on February 16, 2012
Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population. Clin Epidemiol (2017) 1.37
Cost-effectiveness of population-based screening for colorectal cancer. Br J Cancer (2013) 1.06
Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci (2014) 0.89
Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer. World J Gastroenterol (2013) 0.84
Review of economic evidence in the prevention and early detection of colorectal cancer. Health Econ Rev (2013) 0.84
Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Serv Res (2013) 0.82
Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection. Int J Cancer (2014) 0.81
Socioeconomic Disparities in Colorectal Cancer Screening in Korea: A Nationwide Cross-Sectional Study. Medicine (Baltimore) (2015) 0.78
Colorectal cancer screening: the northern trust experience. Ulster Med J (2013) 0.78
Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therap Adv Gastroenterol (2015) 0.76
Reply: cost-effectiveness of population-based screening for colorectal cancer. Br J Cancer (2013) 0.76
Tackling colorectal cancer as a public health issue: what can the gastroenterologist do? Can J Gastroenterol (2012) 0.76
Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis. Medicine (Baltimore) (2016) 0.75
Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. BMC Cancer (2015) 0.75
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening. PLoS One (2017) 0.75
Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing. Appl Transl Genom (2015) 0.75
Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program. World J Gastrointest Oncol (2016) 0.75
Counting the cost of cancer: out-of-pocket payments made by colorectal cancer survivors. Support Care Cancer (2017) 0.75
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med (2001) 8.76
Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med (2006) 8.18
Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA (2004) 6.98
The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med (2004) 6.43
Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol (2006) 6.03
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69
Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (2007) 5.63
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet (2002) 5.04
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology (2008) 4.68
A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med (1996) 4.46
Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med (2005) 4.38
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Meta-analysis: computed tomographic colonography. Ann Intern Med (2005) 3.66
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology (2005) 2.71
Surveillance guidelines after removal of colorectal adenomatous polyps. Gut (2002) 2.71
Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst (1993) 2.65
CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology (2005) 2.48
Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med (1990) 2.48
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncol (2006) 2.32
Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen (2007) 2.30
Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology (2003) 2.16
Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut (1992) 2.15
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther (2003) 2.05
Colorectal serrated adenocarcinoma. Histopathology (2007) 2.04
Quality of life in survivors of colorectal carcinoma. Cancer (2000) 1.99
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer (2009) 1.93
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol (2003) 1.87
Complications of diagnostic and therapeutic colonoscopy within a defined population in Sweden. Gastrointest Endosc (2001) 1.71
The cost-effectiveness of screening for colorectal cancer. CMAJ (2010) 1.67
Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Making (1997) 1.64
Option appraisal of population-based colorectal cancer screening programmes in England. Gut (2006) 1.49
Discounting and decision making in the economic evaluation of health-care technologies. Health Econ (2010) 1.35
Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol (2008) 1.32
Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ (2011) 1.16
Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc (2002) 1.16
Bayesian calibration of a natural history model with application to a population model for colorectal cancer. Med Decis Making (2010) 1.15
Hemoccult sensitivity estimate in a screening program for colorectal cancer in the Province of Florence. Tumori (1991) 1.05
Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol (2007) 1.04
Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach. Gut (2007) 0.98
Cost effectiveness and projected national impact of colorectal cancer screening in France. Endoscopy (2011) 0.98
Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen (1996) 0.97
The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia. Cancer (1987) 0.96
Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut (2002) 0.95
Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen (2007) 0.94
Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis. Int J Cancer (2011) 0.91
Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care (2003) 0.91
Performance improvements of stool-based screening tests. Best Pract Res Clin Gastroenterol (2010) 0.89
Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer. Gut (2008) 0.88
Cost-effectiveness of colorectal cancer screening - an overview. Best Pract Res Clin Gastroenterol (2010) 0.88
Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust (2001) 0.87
Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol (2011) 0.86
Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening. Int J Technol Assess Health Care (2010) 0.86
Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test. Int J Technol Assess Health Care (2010) 0.84
Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy. Hepatogastroenterology (2003) 0.81
Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorectal Dis (1997) 0.81
Screening for colorectal cancer in Italy: 2008 survey. Epidemiol Prev (2011) 0.81
Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. Ir J Med Sci (2011) 0.80
Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective. Scand J Gastroenterol (2010) 0.79
Characteristics of colorectal cancer that produce positive immunochemical occult blood test results on stool obtained by digital rectal examination. Can J Gastroenterol (2001) 0.79
Follow-up of patients undergoing both semiquantitated immunochemical fecal occult blood and colonoscopy examinations. Eur J Cancer Prev (2012) 0.78
[National colorectal cancer screening program in the Republic of Croatia--experiences, outcomes and obstacles in the program implementation in the Medimurje County]. Acta Med Croatica (2010) 0.78
Association of diverticulosis coli and vascular ectasias and the results of fecal occult blood test. Hepatogastroenterology (2001) 0.78
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2003) 10.43
Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ (1999) 9.70
Communication failures in the operating room: an observational classification of recurrent types and effects. Qual Saf Health Care (2004) 5.29
Left-ventricular-volume reduction for end-stage heart failure. Lancet (1997) 3.89
Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell (1992) 3.82
The International Health Program: the fifteen-year experience with Yale University's Internal Medicine Residency Program. Am J Trop Med Hyg (1999) 3.23
Locomotor milestones and babywalkers: cross sectional study. BMJ (2002) 2.85
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2001) 2.65
A randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery. Anaesthesia (2013) 2.63
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Electrical control of antiferromagnetic domains in multiferroic BiFeO3 films at room temperature. Nat Mater (2006) 2.49
RasGRP links T-cell receptor signaling to Ras. Blood (2000) 2.46
Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst (2001) 2.46
Predicting the one-year course of adolescent major depression. J Am Acad Child Adolesc Psychiatry (1995) 2.20
Public health expenditures: developing estimates for improved policy making. J Public Health Manag Pract (1997) 2.19
Characteristics of the cofactor requirements for the superoxide-generating NADPH oxidase of human polymorphonuclear leukocytes. Biochemistry (1981) 2.11
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect (2014) 2.06
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell (2000) 1.98
Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress. Br Med J (1974) 1.92
'Neurophobia'--attitudes of medical students and doctors in Ireland to neurological teaching. Eur J Neurol (2007) 1.91
ABC of rheumatology. Low back pain. BMJ (1995) 1.85
A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technol Assess (2002) 1.84
Physiological and metabolic responses to open and laparoscopic cholecystectomy. Br J Surg (1992) 1.83
The attitudes and practices of general practitioners regarding dementia diagnosis in Ireland. Int J Geriatr Psychiatry (2008) 1.80
Incidence of childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking water: an ecological analysis. Diabetologia (1997) 1.78
Biomechanics of the patellofemoral joint. Clin Orthop Relat Res (1979) 1.76
Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood (1994) 1.75
Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med (2000) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Metalloregulatory DNA-binding protein encoded by the merR gene: isolation and characterization. Science (1987) 1.70
Nucleotide sequence of a chromosomal mercury resistance determinant from a Bacillus sp. with broad-spectrum mercury resistance. J Bacteriol (1989) 1.64
Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess (2004) 1.64
Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63
Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment. Clin Infect Dis (2001) 1.60
The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma (1994) 1.60
The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum Mol Genet (1997) 1.56
Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogues. Biochemistry (1978) 1.55
Getting teams to talk: development and pilot implementation of a checklist to promote interprofessional communication in the OR. Qual Saf Health Care (2005) 1.55
The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord (2005) 1.54
Mechanistic studies on cyclohexanone oxygenase. Biochemistry (1982) 1.54
A randomized controlled trial of an asthma clinical pathway for children in general practice. Acta Paediatr (2005) 1.49
A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol (2006) 1.49
Analytical and preparative high-performance liquid chromatography separation of flavin and flavin analog coenzymes. Anal Biochem (1980) 1.49
Liver iron concentration, stainable iron, and total body storage iron. Gut (1974) 1.48
Emerging advantages and drawbacks of telephone surveying in public health research in Ireland and the U.K. BMC Public Health (2006) 1.47
Suicide substrates for the alanine racemase of Escherichia coli B. Biochemistry (1978) 1.47
Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gamma-lyase during processing of L-propargylglycine. Biochemistry (1979) 1.47
Statistical issues in the analysis of disease mapping data. Stat Med (2001) 1.46
Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet J (2001) 1.46
An examination of linkage of schizophrenia and schizoaffective disorder to the pseudoautosomal region (Xp22.3) Br J Psychiatry (1994) 1.46
Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland. Br J Dermatol (2011) 1.45
Initial experiences with a multidisciplinary approach to decreasing the length of hospital stay for patients undergoing unilateral mastectomy. Eur J Surg Oncol (2011) 1.45
HIV risk of transmission behaviour amongst HIV-infected prisoners and its correlates. Br J Addict (1992) 1.44
The North Dublin randomized controlled trial of structured diabetes shared care. Fam Pract (2004) 1.44
Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ (1992) 1.43
The management of rectal cancer in Ireland in 2007--room for improvement? Surgeon (2010) 1.41
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess (2009) 1.41
Diagnostic value of the apex beat. Lancet (1989) 1.41
Cost of treating stroke in an Irish teaching hospital. Ir Med J (2003) 1.40
Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess (2010) 1.40
Measuring leg muscle and fat mass in humans: comparison of CT and dual-energy X-ray absorptiometry. J Appl Physiol (1985) (2000) 1.40
Complex visual hallucinations in a psychologically normal patient. Ir Med J (2007) 1.39
Prevention of postoperative nausea and vomiting. Ir Med J (2005) 1.39
The 3' end CCA of mature tRNA is an antideterminant for eukaryotic 3'-tRNase. RNA (1999) 1.39
Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw? Ir Med J (2008) 1.39
Oral fluid collection by post for viral antibody testing. Int J Epidemiol (2001) 1.39
A rapid method of production of irregular-shaped fields for use with patients receiving electron radiotherapy. Br J Radiol (1990) 1.39
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med (2000) 1.39
Infantile hypertrophic pyloric stenosis in a regional centre. Ir J Med Sci (2000) 1.39
A comparison of conventional, conformal and intensity-modulated coplanar radiotherapy plans for posterior fossa treatment. Br J Radiol (2004) 1.39
Impact of a critical pathway on postoperative length of stay and outcomes after infrainguinal bypass. J Vasc Surg (1998) 1.38
Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem (1983) 1.37
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol (1996) 1.37
A comparison of three methods of analysis for age-period-cohort models with application to incidence data on non-Hodgkin's lymphoma. Int J Epidemiol (1997) 1.35
Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. J Biomech (1998) 1.33
Microsurgical anatomy of the superficial veins of the cerebrum. Neurosurgery (1985) 1.33
Purification and properties of D-amino acid dehydrogenase, an inducible membrane-bound iron-sulfur flavoenzyme from Escherichia coli B. J Biol Chem (1980) 1.32
Appearance of heat shock proteins during the induction of multiple flagella in Naegleria gruberi. J Biol Chem (1980) 1.32
Comparison of individual follow-up and computerized record linkage using the Canadian Mortality Data Base. Can J Public Health (1989) 1.32
Suicide substrates for flavoprotein enzymes. Methods Enzymol (1978) 1.30
Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol (1975) 1.30
Factor 390 chromophores: phosphodiester between AMP or GMP and methanogen factor 420. Biochemistry (1985) 1.28
Granzyme B-induced loss of mitochondrial inner membrane potential (Delta Psi m) and cytochrome c release are caspase independent. J Immunol (1999) 1.28
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J (2003) 1.27
Depression in rheumatoid arthritis--underscoring the problem. Rheumatology (Oxford) (2006) 1.26
Studies on the mechanism of action of the flavoenzyme lactate oxidase. Oxidation and elimination with beta-chlorolactate. J Biol Chem (1973) 1.25
Persistent expression of canine factor IX in hemophilia B canines. Gene Ther (1999) 1.25
Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen (2008) 1.25
Seasonality of birth of patients with childhood diabetes in Britain. BMJ (1996) 1.24
Clinical findings in Southeast Asian refugees. JAMA (1983) 1.24
Purification and properties of Methanobacterium thermoautotrophicum DNA photolyase. J Biol Chem (1989) 1.23
Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technol Assess (2004) 1.23
Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J Biol Chem (2000) 1.23
Enterobacter sakazakii an emerging bacterial pathogen with implications for infant health. Minerva Pediatr (2007) 1.22